Nominating Committee proposal for decision by the Extra General Meeting on 1 December 2009

Nominating Committee proposal for decision by the Extra General Meeting on 1
December 2009 

As a supplement to that stated in the notice of the Extra General Meeting, the
Nominating Committee of Bure Equity AB (publ), ("Bure"), proposes that:

- the number of Board Members to serve until the next Annual General Meeting be
five,

- the remuneration to the Board Chairman and the other Board Members shall be in
the same amount that was decided at the Annual General Meeting on 28 April 2009,


- Board members Björn Björnsson, Kjell Duveblad, Håkan Larsson and Ann-Sofi
Lodin be re-elected with Björn Björnsson as the new Board Chairman, 

- Mathias Uhlén is elected new Member of the Board.

Mathias Uhlén, born 1954, D.Eng. Professor of microbiology. Since 1992 he is a
Member of the Board of Skanditek Industriförvaltning AB (publ). Furthermore he
is Chairman of the Board of Atlas Antibodies AB and Member of the Board of
Affibody AB, Biotage AB (publ), KTH Holding AB, SweTree Technologies AB, Nordiag
ASA and Novozymes A/S, among other companies. Mathias Uhlén is also a member of
the Royal Academy of Sciences and the Royal Academy of Engineering Sciences.

Patrik Tigerschiöld resigns as Member of the Board.

The resolution regarding the election of new Board Members is conditional upon
the completion of the proposed merger between Bure and Skanditek
Industriförvaltning AB (publ), ("Skanditek"), to be resolved upon at the Extra
General Meeting, and the registration by the Swedish Companies Registration
Office (Bolagsverket). Until the merger has been registered with Bolagsverket,
Bure and Skanditek shall act as two independent and separately listed companies
with their current management and board of directors, respectively.

The Nominating Committee has consisted of Björn Björnsson (Skanditek), Ulf
Strömsten (Catella Fonder), Peter Rudman (Nordeas fonder) and Patrik
Tigerschiöld, Chairman of Bure.

The Nominating Committee's proposal is supported by shareholders representing 30
per cent of the votes for all shares in the company.

Gothenburg, 17 November 2009
Bure Equity AB (publ)


For more information, please contact:
Björn Björnsson, The Chairman of the Nominating Committee
Phone +46 8 614 00 20

__________________________________________________________________

The information contained herein is subject to the disclosure requirements of
Bure Equity AB under the Swedish Securities Market Act. This information has
been publicly communicated on 17 November, 2009,  at 08:30 CET.
__________________________________________________________________

Bure Equity AB (publ), corp. ID No. 556454-8781
P O Box 5419, SE-402 29 Gothenburg
Phone +46 31 708 64 00, Fax +46 31 708 64 80
www.bure.se